Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, Regeneron and FDA
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary disease received approval from the Food and Drug Administration.
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Regeneron stock XX on XX after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.
17h
Sanofi blockbuster drug wins clearance in US for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
MedPage Today
17h
First-Ever Biologic Approved for COPD
The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Promotes watch collection
Troops to leave some bases
Congressional Gold Medal
NC dam failure ‘imminent’
Haney sues Garcia
ICE: Convicts roaming free
Dow closes at record high
Ending password-sharing
Boxes to distribute Narcan
KY sues Express Scripts
Fake Biden robocalls fine
Producing doc on Diddy
50/50 ball ownership suit
World's oldest cheese found
Fed inflation gauge cools
US charges three Iranians
Pleads not guilty
Urgent safety alert for 737s
NY ballot appeal rejected
ISR targets Hezbollah HQ
Killer gets life sentence
Bill to use birth control
Van Gogh paintings attacked
Diocese reaches settlement
Meta hit with privacy fine
Deposition in AI suit
Feedback